Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 79
- Registration Number
- NCT05294900
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Comparison of the Clinical Performance and Safety of the Ambu®AuraGainTM Laryngeal Mask in Children Undergoing Surgery in the Supine and Prone Position - A Prospective, Noninferiority Clinical Trial
Completed
- Conditions
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 126
- Registration Number
- NCT05286021
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 56
- Registration Number
- NCT05286060
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 80
- Registration Number
- NCT05280236
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 21
- Registration Number
- NCT05280457
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Catheter-directed Sclerotherapy Versus Surgical Resecction: Randomized Controlled Trial Comparing Ovarian Function and Therapeutic Efficacy After Treatment of Ovarian Endometrioma
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 98
- Registration Number
- NCT05279209
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations
- First Posted Date
- 2022-03-14
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 36
- Registration Number
- NCT05277701
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella Trial
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 50
- Registration Number
- NCT05270889
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Nivolumab for Recurrent/Metastatic Carcinosarcoma
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 28
- Registration Number
- NCT05224999
- Locations
- 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Analgesic Effect of Intrathecal Morphine Combined With Low Dose Local Anesthetics on Postoperative Analgesia After Liver Resection
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 90
- Registration Number
- NCT05208801
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath